CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment.

Oncoimmunology · 2022 · PMC9427044 · PMID 36052217

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Flow cytometry analysis of tumor samples showed a trend toward a decline in M2 macrophage infiltration and an increase in M1 macrophage infiltration ( Figure 3a,b ), accounting for an average two-fold increase in the M1/M2 ratio (p = 0.056; Figure 3c ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.